Urinary Cross-Linked N-Telopeptide (NTX)
Specific cross-linked amino-terminal telopeptide degradation fragment of type I collagen released during osteoclastic bone resorption.
Standard vs. Optimal Reference RangesnM BCE/mM Cr
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
15 - 65 nM BCE/mM Cr (females), 10 - 55 nM BCE/mM Cr (males)
General reference distribution across unselected commercial populations.
20 - 45 nM BCE/mM Cr
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Formed when osteoclasts secrete cathepsin K and hydrochloric acid into the sealing zone, dissolving mineralized bone matrix.
Differential Diagnosis
Elevated Levels (NTX High)
- •High-turnover osteoporosis and accelerated bone loss
- •Paget disease of bone
- •Osteolytic bone metastases
- •Primary hyperparathyroidism
Low Levels (NTX Low)
- •Effective anti-resorptive therapeutic response
- •Adynamic low-turnover bone state
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for NTX
- Targeted organ system imaging or functional dynamic testing related to bone resorption osteoclast breakdown
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Urinary Cross-Linked N-Telopeptide - The New England Journal of Medicine (2021). PMID: 34190124
- [2]NTX Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Urinary Cross-Linked N-Telopeptide (NTX) into overall healthspan optimization.